Results of Meeting
|
9 December 2021 at 1:35pm
|
AGM Presentation to Shareholders
|
9 December 2021 at 11:25am
|
Release of Shares from Voluntary Escrow
|
7 December 2021 at 7:10pm
|
Cellmid receives R&D tax credit
|
10 November 2021 at 10:00am
|
Proposed issue of securities - CDY
|
9 November 2021 at 5:10pm
|
Letter to Shareholders - Notice of Annual General Meeting
|
9 November 2021 at 5:00pm
|
Notice of Annual General Meeting/Proxy Form
|
9 November 2021 at 5:00pm
|
Jobkeeper Payments Notification
|
8 November 2021 at 6:50pm
|
Initial Director's Interest Notice - Christopher
|
8 November 2021 at 6:50pm
|
Final Director's Interest Notice - Eck-Thompson
|
8 November 2021 at 6:50pm
|
Becoming a substantial holder from HNG
|
5 November 2021 at 10:45am
|
Appointment of Non-Executive Director
|
2 November 2021 at 12:00pm
|
Cleansing Notice
|
2 November 2021 at 11:10am
|
Application for quotation of securities - CDY
|
2 November 2021 at 11:00am
|
BLC Cosmetics Acquisition Completed
|
2 November 2021 at 10:55am
|
Results of Meeting
|
22 October 2021 at 12:55pm
|
General Meeting Presentation
|
22 October 2021 at 11:05am
|
Appendix 4C and Quarterly Activity Report
|
20 October 2021 at 9:25am
|
Notification of cessation of securities - CDY
|
14 October 2021 at 9:30am
|
Investor Webinar
|
27 September 2021 at 9:55am
|
Change of Director's Interest Notice - Halasz
|
24 September 2021 at 2:05pm
|
Letter to Shareholders - Notice of General Meeting
|
22 September 2021 at 2:50pm
|
Notice of General Meeting/Proxy Form
|
22 September 2021 at 2:35pm
|
Appendix 4G and Corporate Governance Statement
|
20 September 2021 at 10:25am
|
Annual Report to shareholders
|
20 September 2021 at 10:15am
|
HNG: BLC Cosmetics to merge with Cellmid
|
16 September 2021 at 9:45am
|
Proposed issue of securities - CDY
|
16 September 2021 at 9:40am
|
Cellmid to Acquire BLC Cosmetics Pty Ltd
|
16 September 2021 at 9:35am
|
Appendix 4E and FY21 Financial Report
|
19 August 2021 at 4:55pm
|
Appendix 4C and Quarterly Activity Report
|
20 July 2021 at 10:20am
|
Notification of cessation of securities - CDY
|
9 July 2021 at 12:35pm
|
MarketLit Investor Conference Presentation
|
2 July 2021 at 8:50am
|
Cellmid Reports Record QVC Sales
|
17 June 2021 at 9:55am
|
Release of Shares from Voluntary Escrow
|
11 June 2021 at 9:25am
|
FGF5 Inhibitors Supply Agreement - Additional Information
|
10 June 2021 at 11:25am
|
Supply Agreement for Cellmid's FGF5 Inhibitors
|
8 June 2021 at 10:05am
|
Investor Briefing and Presentation
|
3 May 2021 at 10:00am
|
Chinese Import Permits Received
|
30 April 2021 at 10:20am
|
Investor Briefing
|
29 April 2021 at 5:35pm
|
Agreement Signed for Sale of Lyramid Limited
|
29 April 2021 at 11:55am
|
Appendix 4C and Quarterly Activity Report
|
23 April 2021 at 10:15am
|
Change of Director's Interest Notice - Eck
|
1 April 2021 at 4:15pm
|
Change of Director's Interest Notice - Cross
|
1 April 2021 at 4:15pm
|
Change of Director's Interest Notice - Halasz
|
1 April 2021 at 4:05pm
|
Change of Director's Interest Notice - Gordon
|
1 April 2021 at 4:05pm
|
CDYOA Top20 and Distribution List
|
1 April 2021 at 4:00pm
|
Appendix 2A
|
1 April 2021 at 12:10pm
|
Supplementary Prospectus
|
31 March 2021 at 7:10pm
|
Proposed issue of Securities - CDY
|
31 March 2021 at 4:40pm
|
Rights Issue Closed with Strong Demand
|
31 March 2021 at 4:20pm
|